Ali Rashidfarrokhi

Ali Rashidfarrokhi

Auto-generated profile, based on publicly available information

Ali Rashidfarrokhi

Department of Pathology, New York University Grossman School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JHJohannes Hartl
Johannes Hartl
LSLee Serpas
Lee Serpas
YWYueyang Wang
Yueyang Wang
ARAli Rashidfarrokhi
Ali Rashidfarrokhi
OPOriana A. Perez
Oriana A. Perez
BRBoris Reizis
Boris Reizis
Antibodies to double-stranded DNA (dsDNA) are prevalent in systemic lupus erythematosus (SLE), particularly in patients with lupus nephritis, yet the nature and regulation of antigenic cell-free DNA (cfDNA) are poorly understood. Null mutations in the secreted DNase DNASE1L3 cause human monogenic SLE with anti-dsDNA autoreactivity. We report that >50% of sporadic SLE patients with nephritis manifested reduced DNASE1L3 activity in circulation, which was associated with neutralizing autoantibodies to DNASE1L3. These patients had normal total plasma cfDNA levels but showed accumulation of cfDNA in circulating microparticles. Microparticle-associated cfDNA contained a higher fraction of longer polynucleosomal cfDNA fragments, which bound autoantibodies with higher affinity than mononucleosomal fragments. Autoantibodies to DNASE1L3-sensitive antigens on microparticles were prevalent in SLE nephritis patients and correlated with the accumulation of cfDNA in microparticles and with disease severity. DNASE1L3-sensitive antigens included DNA-associated proteins such as HMGB1. Our results reveal autoantibody-mediated impairment of DNASE1L3 activity as a common nongenetic mechanism facilitating anti-dsDNA autoreactivity in patients with severe sporadic SLE.

5 October 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SUSamik Upadhaya
Samik Upadhaya
CSCatherine M. Sawai
Catherine M. Sawai
EPEfthymia Papalexi
Efthymia Papalexi
ARAli Rashidfarrokhi
Ali Rashidfarrokhi
GJGeunhyo Jang
Geunhyo Jang
BRBoris Reizis
Boris Reizis
Adult hematopoiesis has been studied in terms of progenitor differentiation potentials, whereas its kinetics in vivo is poorly understood. We combined inducible lineage tracing of endogenous adult hematopoietic stem cells (HSCs) with flow cytometry and single-cell RNA sequencing to characterize early steps of hematopoietic differentiation in the steady-state. Labeled cells, comprising primarily long-term HSCs and some short-term HSCs, produced megakaryocytic lineage progeny within 1 wk in a process that required only two to three cell divisions. Erythroid and myeloid progeny emerged simultaneously by 2 wk and included a progenitor population with expression features of both lineages. Myeloid progenitors at this stage showed diversification into granulocytic, monocytic, and dendritic cell types, and rare intermediate cell states could be detected. In contrast, lymphoid differentiation was virtually absent within the first 3 wk of tracing. These results show that continuous differentiation of HSCs rapidly produces major hematopoietic lineages and cell types and reveal fundamental kinetic differences between megakaryocytic, erythroid, myeloid, and lymphoid differentiation.

16 March 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KLKeenan Lacey
Keenan Lacey
LSLee Serpas
Lee Serpas
SMSohei Makita
Sohei Makita
YWYueyang Wang
Yueyang Wang
ARAli Rashidfarrokhi
Ali Rashidfarrokhi
BRBoris Reizis
Boris Reizis
Extracellular DNase DNASE1L3 maintains tolerance to self-DNA in humans and mice, whereas the role of its homolog DNASE1 remains controversial, and the overall function of secreted DNases in immunity is unclear. We report that deletion of murine DNASE1 neither caused autoreactivity in isolation nor exacerbated lupus-like disease in DNASE1L3-deficient mice. However, combined deficiency of DNASE1 and DNASE1L3 rendered mice susceptible to bloodstream infection with Staphylococcus aureus. DNASE1/DNASE1L3 double-deficient mice mounted a normal innate response to S. aureus and did not accumulate neutrophil extracellular traps (NETs). However, their kidneys manifested severe pathology, increased bacterial burden, and biofilm-like bacterial lesions that contained bacterial DNA and excluded neutrophils. Furthermore, systemic administration of recombinant DNASE1 protein during S. aureus infection rescued the mortality of DNase-deficient mice and ameliorated the disease in wild-type mice. Thus, DNASE1 and DNASE1L3 jointly facilitate the control of bacterial infection by digesting extracellular microbial DNA in biofilms, suggesting the original evolutionary function of secreted DNases as antimicrobial agents.

28 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RPRay Pillai
Ray Pillai
SLSarah E. LeBoeuf
Sarah E. LeBoeuf
YHYuan Hao
Yuan Hao
CNConnie New
Connie New
JBJenna L. E. Blum
Jenna L. E. Blum
TPThales Papagiannakopoulos
Thales Papagiannakopoulos
Loss-of-function mutations in KEAP1 frequently occur in lung cancer and are associated with resistance to standard of care treatment, highlighting the need for the development of targeted therapies. We have previously shown that KEAP1 mutant tumors have increased glutamine consumption to support the metabolic rewiring associated with NRF2 activation. Here, using patient-derived xenograft models and antigenic orthotopic lung cancer models, we show that the novel glutamine antagonist DRP-104 impairs the growth of KEAP1 mutant tumors. We find that DRP-104 suppresses KEAP1 mutant tumor growth by inhibiting glutamine-dependent nucleotide synthesis and promoting anti-tumor CD4 and CD8 T cell responses. Using multimodal single-cell sequencing and ex vivo functional assays, we discover that DRP-104 reverses T cell exhaustion and enhances the function of CD4 and CD8 T cells culminating in an improved response to anti-PD1 therapy. Our pre-clinical findings provide compelling evidence that DRP-104, currently in phase 1 clinical trials, offers a promising therapeutic approach for treating patients with KEAP1 mutant lung cancer. Furthermore, we demonstrate that by combining DRP-104 with checkpoint inhibition, we can achieve suppression of tumor intrinsic metabolism and augmentation of anti-tumor T cell responses.

1 March 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
PNPatrick Niekamp
Patrick Niekamp
GGGaelen Guzman
Gaelen Guzman
HLHans Leier
Hans Leier
ARAli Rashidfarrokhi
Ali Rashidfarrokhi
VRVeronica Richina
Veronica Richina
FTFikadu Tafesse
Fikadu Tafesse
Tuberculosis, the pathological result of infection by Mycobacterium tuberculosis ( M.tb ), represents a massive and persistent global health burden with vast overrepresentation in regions with poor access to healthcare. This pathogen survives intracellularly within lung macrophages, and has been shown to extensively reprogram the host lipid compartment to the effect of enhanced survival and immune evasion. Sphingolipids are a class of lipid with extensive functions in a wide variety of cellular contexts, including apoptosis, autophagy, stress response, and inflammation. There remains a significant knowledge gap surrounding the lipid-mediated interactions between M.tb and its host. Our investigation aims to explore the mechanisms through which M.tb harnesses host-derived sphingolipids to gain entry to the host and to survive intracellularly. To this end, we use chemical and genetic perturbations of the sphingolipid de novo synthesis pathway and fluorescence microscopy to show that sphingolipids are required for efficient phagocytosis of M.tb . We furthermore show that the dynamics of phosphoinositides at the phagosomal synapse are perturbed upon blockade of sphingolipid synthesis. Finally, we demonstrate that perturbing the homeostasis of a specific sphingolipid (sphingomyelin) through both enrichment and depletion at the cell surface reduces M.tb uptake. This work represents a first step in building comprehensive knowledge of the mechanisms of host-pathogen interactions in M.tb , and demonstrates a cohort of methodologies that may be applied to a variety of pathogenic contexts.

1 May 2023
Verified
Conference Paper
Closed access
RPR. Pillai
R. Pillai
ARA. Rashidfarrokhi
A. Rashidfarrokhi
YHY. Hao
Y. Hao
KWK.-K. Wong
K.-K. Wong
SKS. Koide
S. Koide
TPT. Papagiannakopoulos
T. Papagiannakopoulos